Comparison of high and low iris acid levels in a large cohort of gout patients shows high SUA associated with more comorbidities and CKD, more colchicine & indocin use. #EULAR2019 SAT0435 pic.twitter.com/FvUU4Q6Ky9

— Dr. John Cush (@RheumNow) June 17, 2019

Dr. Peter Lipsky – 1 Million #Gout Patients & who cares for them. SAT0435 #EULAR2018 https://t.co/WfFR4tRf2p

— Dr. John Cush (@RheumNow) June 17, 2019

RheumNow expanded twitter coverage of the #EULAR2019 annual meeting is sponsored by Horizon Pharma. All content chosen by RheumNow & its Faculty.

— Dr. John Cush (@RheumNow) June 16, 2019

More in #gout news from #EULAR2019: men on uric acid-lowering therapy (and only 1/3 of people in this study were) were less likely to visit the #ER than those who weren’t

— CreakyJoints.org (@CreakyJoints) June 15, 2019

RheumNow expanded twitter coverage of the #EULAR2019 annual meeting is sponsored by Horizon Pharma. All content chosen by RheumNow & its Faculty.

— Dr. John Cush (@RheumNow) June 15, 2019

#Hyperuricemia (HUC) /#gout found to be associated with CVD in a cohort of 37,315 PsA patients. Investigators at Icahn Mt Sinai saw higher rates of Afib and HF (with preserved ejection fraction) in patients with hyperuricemia/gout vs those without. SAT0371 #EULAR2019 @RheumNow pic.twitter.com/98B3JSFSnv

— Gout Study Group (@GoutGroup) June 15, 2019

Dr Alex So reviews his selection of #gout #uratedepositiondisease highlights Days 1-3 at EULAR 2019 in Madrid #EULAR2019 @RheumNow https://t.co/IqIfXBkv24

— Gout Study Group (@GoutGroup) June 14, 2019

#EULAR2019 session ‘Getting A Grip on The Comorbidities in Gout’ focused on the complex and variable disease profile patients experience and clinicians treat. Do #gout co-morbidities occur in patterns? Dr Ed Roddy discusses. Abstract SP0061 @RheumNow pic.twitter.com/EHoNdP7iMo

— Gout Study Group (@GoutGroup) June 14, 2019

New gout risk factor identified in #EULAR2019 research: dust from occupational exposure (such jobs as cleaners, plumbers, electricians, welders, and mechanics) significantly raised the risk of developing gout.

— CreakyJoints.org (@CreakyJoints) June 12, 2019

Patients with #gout have high athersclerosis (hardening of the arteries) on ultrasounds even without other signs of heart disease. Speaks to importance of reducing #heartdisease risk factors! pic.twitter.com/C4jUYq2iNm

— CreakyJoints.org (@CreakyJoints) June 13, 2019

#Gout independent association between gout and all form of cardiovascular diseases. MSU crystals removal should help to subside CV risk, but available data is conflicted.. Dr. Mariano Andrés #EULAR2019 pic.twitter.com/3GlJCvIPa7

— Dr.Martínez (@MtzReuma) June 13, 2019

RheumNow expanded twitter coverage of the #EULAR2019 annual meeting is sponsored by Horizon Pharma. All content chosen by RheumNow & its Faculty.

— Dr. John Cush (@RheumNow) June 14, 2019

Reade Amsterdam Gout study of 75 gout (many polyarticular) found neutrophil extracellular traps or NETS are increased in #gout patients and NETS correlate with cardiovascular risk. #Eular2019 OP0300 pic.twitter.com/ZVeL9ltF7B

— Dr. John Cush (@RheumNow) June 14, 2019

Clinical practice-friendly VAS assessIng different aspects of Rheum diseases: physicians rated #gout inflammation, damage, and global scores as high/higher than RA. Dr Nika discusses. Let’s have high levels of gout treat-to-target strategy discussions too! @RheumNow #EULAR2019 pic.twitter.com/wMf7yR2GPA

— Gout Study Group (@GoutGroup) June 14, 2019

Health care providers and patients with #gout working together to achieve the sUA target matters! Increased mortality risk in a large, long term cohort when target <6 mg/dL not achieved. OP0052. See Dr. Perez-Ruiz’s summary of his findings @Rheumnow #gouttreatment #EULAR2019 pic.twitter.com/sBHR5qXfa7

— Gout Study Group (@GoutGroup) June 13, 2019

#Comorditiy is common in #gout & distinct #clusters form. #allopurinol can be safely be used in #ckd at higher than historically suggested doses. Uncertainty remains around association between gout & #neurodegeneration. #EULAR2019 @GoutEducation @GoutandYou @PCSciences @elinlowri pic.twitter.com/7z6ZkbnZRZ

— Dr James Prior (@DrJamesPrior) June 13, 2019

Comorbidity is common in gout, is challenging in CKD, allopurinol can be safely dosed higher than historical, uncertainty about relationships between urate gout and neurodegeneration .. avoid <3mg/dl in long term.. Dr. Roddy UK @KeeleUniversity #EULAR2019 pic.twitter.com/TvESMxHG6y

— Dr.Martínez (@MtzReuma) June 13, 2019

#Gout patients tend not to tell doctors impact of gout on quality of life

👉🏼43% #mentalhealth
👉🏼27% impact on family
👉🏼26% relationship with partners

➡️🔟% lost job or retired due to gout

by Meulemeester #EULAR2019 pic.twitter.com/fyrAyvpaYO

— Dr Ai Lyn Tan (@DrAiLynTan) June 13, 2019

https://t.co/V10S4oVFsv would love to feature your tweets in our coverage of #EULAR2019 from Madrid. Be sure to include these 3 in your tweet- @RheumNow #EULAR2019 & the abstract # pic.twitter.com/WqqX4w4dmd

— Dr. John Cush (@RheumNow) June 10, 2019